
Massachusetts Lawmakers Prioritize Health Policy
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.

Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
As many of you may have heard, CMS released a ton of data today on prices. What’s it mean? What should we do about it?
Over the past 20 years, hospitals have gradually implemented many safety improvements to reduce the number of hospital-onset central line associated blood stream infections (CLABSIs).
A few commenters have questioned my power calculation on the Oregon Medicaid study, claiming different results. Though I can’t be sure what they are doing wrong
Is this really controversial? Evidently, some of you think it is. I was reading a Viewpoint in JAMA when I stumbled across this (emphasis mine):
Answering some questions about power calculations: 1) What is a power calculation? It’s a calculation that tells you, given sample sizes, assumed baseline risk, and
By Jennifer Schwartz and Steven Pearson in JAMA Internal Medicine: Methodological statements for clinical guidance documents indicated that 17 of 30 physician societies (57%) explicitly integrated
The recent debate over the work of Reinhart and Rogoff, as well as over the Oregon Medicaid study, offers a good opportunity to reflect on
A follow-up to this post is here. It includes instructions on how to run your own power calculations. Kevin Drum: Let’s do the math. In
This question is kicking around the blogosphere and Twitter. The current interest is inspired by the incorrect view that the latest Oregon Health Study paper
Highlights from this 2 day conference: Peter Barton Hutt, the dean of the FDA bar, on the last 50 years at the FDA. For example,
Wednesday’s New England Journal of Medicine article on the Oregon Medicaid lottery has provoked a firestorm of reaction. I’m not sure what I can add